Tracked deals
3
3 tracked deals across 2021-2022.
Cary, North Carolina, United States
THREAD provides a clinical research technology platform and scientific consulting services to help life sciences organizations design, operate, and scale decentralized clinical trials (DCT) and electronic clinical outcome assessments (eCOA) for participants, sites, and study teams.
Tracked deals
3
3 tracked deals across 2021-2022.
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
2 buyout · 1 addon
Last 2 years
Supporting Data
THREAD has acquired CureClick, a Costa Mesa-based crowdsourcing platform that accelerates awareness and participation in clinical research. The deal brings CureClick’s community of more than 6,500 ambassadors and a reach of over one million patients into THREAD’s decentralized clinical trials (DCT) platform; CureClick founder Fabio Gratton will join THREAD as chief experience officer.
THREAD, a Cary, North Carolina-based decentralized clinical trials technology and service provider, has acquired inVibe, a voice-powered research and insights technology company focused on life sciences and healthcare. The deal integrates inVibe’s voice capture, NLP and linguist-led analysis into THREAD’s platform as an add-on capability to broaden patient-centered research, recruitment and real‑time insight offerings; financial terms were not disclosed.
THREAD has acquired Modus Outcomes to combine its decentralized clinical trial (DCT) technology platform with Modus' clinical outcomes consulting, psychometrics and biostatistics capabilities. The deal (financial terms not disclosed) expands THREAD's scientific capabilities and global footprint — adding Modus' offices in London and Lyon and a team of ~40 experts to THREAD's DCT offering.
Turn tracked acquisition activity into an outreach-ready buyer list.